A detailed history of Centiva Capital, LP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Centiva Capital, LP holds 4,469 shares of EW stock, worth $295,669. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,469
Holding current value
$295,669
% of portfolio
0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$59.7 - $93.78 $266,799 - $419,102
4,469 New
4,469 $294,000
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $919,226 - $1.21 Million
12,672 Added 182.73%
19,607 $1.87 Million
Q4 2023

Feb 14, 2024

SELL
$61.71 - $77.76 $994,641 - $1.25 Million
-16,118 Reduced 69.92%
6,935 $528,000
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $274,418 - $369,878
3,961 Added 20.75%
23,053 $1.6 Million
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $1.55 Million - $1.8 Million
19,092 New
19,092 $1.8 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $261,195 - $340,216
3,171 New
3,171 $262,000
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $410,405 - $489,527
-3,988 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $334,353 - $417,782
3,988 New
3,988 $413,000
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $756,974 - $963,297
-10,559 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$67.19 - $87.44 $271,447 - $353,257
-4,040 Reduced 27.67%
10,559 $843,000
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $840,026 - $1.12 Million
14,599 New
14,599 $1.01 Million
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $165,301 - $255,474
-3,154 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $186,420 - $213,434
2,600 Added 469.31%
3,154 $736,000
Q2 2019

Aug 13, 2019

BUY
$55.74 - $64.41 $30,879 - $35,683
554 New
554 $102,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.